Found 24 matching trials
Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP) PHASE2 The goals of this clinical study are to learn more about the study drug len...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy PHASE1 Background:
Antiretroviral viral therapy (ART) allows people with human im...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children PHASE2 The goal of this clinical study is to learn more about the study drug, lena...
Show More Location
Grady Health System, Ponce De Leon Center
Learn More & Join Trial
Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment PHASE2 The study will have two portions: Phase 2 and Phase 3. Phase 2 will further...
Show More Location
Midway Immunology and Research Center
Learn More & Join Trial
HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots N/A The goal of this observational study is to establish an operational framewo...
Show More Location
University of Colorado Hospital (UCHealth)
Learn More & Join Trial
A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection PHASE2 The goal of this study is to test the effectiveness, safety, and tolerabili...
Show More Status
Active Not Recruiting
Location
Ruane Clinical Research Group, Inc.
Learn More & Join Trial
Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP) PHASE3 The goal of this clinical study is to learn more about the study drug lenac...
Show More Status
Active Not Recruiting
Location
UAB Sexual Health Research Clinic
Learn More & Join Trial
A Study to Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections Are Tolerable and Acceptable When Administered to Healthy Adults Without HIV PHASE1 This study will evaluate the tolerability and acceptability of injection si...
Show More Status
Active Not Recruiting
Location
GSK Investigational Site
Learn More & Join Trial
Real World Use of Lenacapavir, as an add-on to an Optimized Background Regimen in France N/A For most people with HIV (PWH), an effective antiretroviral regimen can be ...
Show More Location
Hôpital Pitié-Salpêtrière
Learn More & Join Trial
The TAIL-PrEP Study NA The goal of the TAIL-PrEP study is to understand how to support the safe di...
Show More Location
Columbia University Irving Medical Center / NewYork-Presbyterian Hospital
Learn More & Join Trial